Altimmune, Inc. (LON: 0A4C)
London
· Delayed Price · Currency is GBP · Price in USD 6.93
+0.00 (0.06%)
At close: Jan 22, 2025
Altimmune Revenue
Altimmune had revenue of $5.00K USD in the quarter ending September 30, 2024, a decrease of -98.62%. This brings the company's revenue in the last twelve months to $52.00K, down -81.36% year-over-year. In the year 2023, Altimmune had annual revenue of $426.00K, down -726.47%.
Revenue (ttm)
$52.00K
Revenue Growth
-81.36%
P/S Ratio
n/a
Revenue / Employee
$881.36
Employees
59
Market Cap
400.78M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 426.00K | 494.00K | -726.47% |
| Dec 31, 2022 | -68.00K | -4.48M | -101.54% |
| Dec 31, 2021 | 4.41M | -3.78M | -46.12% |
| Dec 31, 2020 | 8.19M | 2.38M | 41.09% |
| Dec 31, 2019 | 5.80M | -4.53M | -43.85% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 221.41B |
| AstraZeneca | 38.20B |
| HSBC Holdings | 43.25B |
| Unilever | 51.12B |
| Rio Tinto Group | 42.87B |
| RELX PLC | 9.30B |
| BP p.l.c. | 144.69B |
| British American Tobacco p.l.c. | 26.18B |